Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stebbins

Showing results (1011-1020 of 1,116) with videos related to

Pageof 112
Sort By:
Neuroepidemiology|June 17, 2020
Validation of the Hebrew Version of the Unified Dyskinesia Rating ScaleAchinoam Faust-Socher, Saar Anis, Meir Kestenbaum, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonistNicholas Stock, Deborah Volkots, Karin Stebbins, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
Parkinsonism & Related Disorders|October 3, 2017
Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleJennifer Zitser, Chava Peretz, Aya Ber David, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Dystonia (Lausanne, Switzerland)|April 27, 2023
From null to midline: changes in head posture do not predictably change head tremor in cervical dystoniaJeanne P Vu, Elizabeth Cisneros, Jerry Zhao, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Journal of Movement Disorders|March 15, 2022
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating ScalePriya Jagota, Prachaya Srivanitchapoom, Sitthi Petchrutchatachart, et al.
Neurologia I Neurochirurgia Polska|July 9, 2020
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)Joanna Siuda, Magdalena Boczarska-Jedynak, Sławomir Budrewicz, et al.
Pageof 112

Showing results (1011-1020 of 1,116) with videos related to

Sort By:
Pageof 112
Neuroepidemiology|June 17, 2020
Validation of the Hebrew Version of the Unified Dyskinesia Rating ScaleAchinoam Faust-Socher, Saar Anis, Meir Kestenbaum, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonistNicholas Stock, Deborah Volkots, Karin Stebbins, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
Parkinsonism & Related Disorders|October 3, 2017
Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleJennifer Zitser, Chava Peretz, Aya Ber David, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Dystonia (Lausanne, Switzerland)|April 27, 2023
From null to midline: changes in head posture do not predictably change head tremor in cervical dystoniaJeanne P Vu, Elizabeth Cisneros, Jerry Zhao, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Journal of Movement Disorders|March 15, 2022
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating ScalePriya Jagota, Prachaya Srivanitchapoom, Sitthi Petchrutchatachart, et al.
Neurologia I Neurochirurgia Polska|July 9, 2020
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)Joanna Siuda, Magdalena Boczarska-Jedynak, Sławomir Budrewicz, et al.
Pageof 112